Clinical Trials Browser

Has results × Neoplasms × olaratumab × Clear all

NCT02377752 2021-02-17

A Study of Olaratumab in Japanese Participants With Advanced Cancer

Phase 1 Completed

25 enrolled 19 charts

Neoplasms

NCT00913835 2019-09-26

A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

Phase 2 Completed

125 enrolled 20 charts

Neoplasms, Ovarian Neoplasms